SIMILAR PATTERNS OF AMINO ACIDS FOR 4P65_G_IPHG101_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1f6f | PLACENTAL LACTOGEN (Ovis aries) |
PF00103(Hormone_1) | 5 | LEU A 157LEU A 172HIS A 98LEU A 97ALA A 100 | None | 1.05A | 4p65B-1f6fA:undetectable4p65D-1f6fA:undetectable4p65G-1f6fA:undetectable4p65H-1f6fA:undetectable | 4p65B-1f6fA:12.364p65D-1f6fA:12.364p65G-1f6fA:10.424p65H-1f6fA:12.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fy2 | ASPARTYL DIPEPTIDASE (Salmonellaenterica) |
PF03575(Peptidase_S51) | 5 | LEU A 94VAL A 85LEU A 103LEU A 147ALA A 146 | None | 1.15A | 4p65B-1fy2A:undetectable4p65D-1fy2A:undetectable4p65G-1fy2A:undetectable4p65H-1fy2A:undetectable | 4p65B-1fy2A:8.104p65D-1fy2A:8.104p65G-1fy2A:8.594p65H-1fy2A:8.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gzk | RAC-BETASERINE/THREONINEPROTEIN KINASE (Homo sapiens) |
PF00069(Pkinase)PF00433(Pkinase_C) | 5 | VAL A 246CYH A 345LEU A 381LEU A 373ALA A 377 | None | 1.00A | 4p65B-1gzkA:undetectable4p65D-1gzkA:undetectable4p65G-1gzkA:undetectable4p65H-1gzkA:undetectable | 4p65B-1gzkA:10.134p65D-1gzkA:10.134p65G-1gzkA:7.944p65H-1gzkA:10.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1j33 | COBT (Thermusthermophilus) |
PF02277(DBI_PRT) | 5 | LEU A 249HIS A 283LEU A 290LEU A 259ALA A 258 | None | 1.05A | 4p65B-1j33A:undetectable4p65D-1j33A:undetectable4p65G-1j33A:undetectable4p65H-1j33A:undetectable | 4p65B-1j33A:5.524p65D-1j33A:5.524p65G-1j33A:5.834p65H-1j33A:5.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1luf | MUSCLE-SPECIFICTYROSINE KINASERECEPTOR MUSK (Rattusnorvegicus) |
PF07714(Pkinase_Tyr) | 5 | LEU A 791LEU A 855CYH A 698LEU A 702ALA A 705 | None | 1.04A | 4p65B-1lufA:undetectable4p65D-1lufA:undetectable4p65G-1lufA:undetectable4p65H-1lufA:undetectable | 4p65B-1lufA:6.344p65D-1lufA:6.344p65G-1lufA:4.474p65H-1lufA:6.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1n31 | L-CYSTEINE/CYSTINELYASE C-DES (Synechocystissp. PCC 6714) |
PF00266(Aminotran_5) | 5 | LEU A 174VAL A 194CYH A 183LEU A 150ALA A 146 | None | 1.12A | 4p65B-1n31A:undetectable4p65D-1n31A:undetectable4p65G-1n31A:undetectable4p65H-1n31A:undetectable | 4p65B-1n31A:9.134p65D-1n31A:9.134p65G-1n31A:3.954p65H-1n31A:9.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nfi | I-KAPPA-B-ALPHA (Homo sapiens) |
PF00023(Ank)PF12796(Ank_2) | 5 | LEU E 187VAL E 160LEU E 148LEU E 205ALA E 207 | None | 1.03A | 4p65B-1nfiE:undetectable4p65D-1nfiE:undetectable4p65G-1nfiE:undetectable4p65H-1nfiE:undetectable | 4p65B-1nfiE:11.764p65D-1nfiE:11.764p65G-1nfiE:7.774p65H-1nfiE:11.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qpo | QUINOLINATE ACIDPHOSPHORIBOSYLTRANSFERASE (Mycobacteriumtuberculosis) |
PF01729(QRPTase_C)PF02749(QRPTase_N) | 5 | LEU A 67LEU A 60LEU A 100LEU A 93ALA A 95 | None | 1.09A | 4p65B-1qpoA:undetectable4p65D-1qpoA:undetectable4p65G-1qpoA:undetectable4p65H-1qpoA:undetectable | 4p65B-1qpoA:5.754p65D-1qpoA:5.754p65G-1qpoA:4.584p65H-1qpoA:5.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ta3 | XYLANASE INHIBITORPROTEIN I (Triticumaestivum) |
PF00704(Glyco_hydro_18) | 5 | VAL A 123LEU A 143LEU A 86LEU A 95ALA A 92 | None | 1.13A | 4p65B-1ta3A:undetectable4p65D-1ta3A:undetectable4p65G-1ta3A:undetectable4p65H-1ta3A:undetectable | 4p65B-1ta3A:10.734p65D-1ta3A:10.734p65G-1ta3A:8.384p65H-1ta3A:10.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ttw | SECRETION CHAPERONE (Yersinia pestis) |
PF05932(CesT) | 5 | LEU A 57CYH A 81LEU A 91LEU A 119ALA A 54 | None | 0.96A | 4p65B-1ttwA:undetectable4p65D-1ttwA:undetectable4p65G-1ttwA:undetectable4p65H-1ttwA:undetectable | 4p65B-1ttwA:15.054p65D-1ttwA:15.054p65G-1ttwA:9.354p65H-1ttwA:15.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wlj | INTERFERONSTIMULATED GENE20KDA (Homo sapiens) |
PF00929(RNase_T) | 5 | LEU A 91CYH A 28LEU A 25LEU A 98ALA A 97 | None | 1.14A | 4p65B-1wljA:undetectable4p65D-1wljA:undetectable4p65G-1wljA:undetectable4p65H-1wljA:undetectable | 4p65B-1wljA:11.394p65D-1wljA:11.394p65G-1wljA:7.844p65H-1wljA:11.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1woi | AGMATINASE (Deinococcusradiodurans) |
PF00491(Arginase) | 5 | LEU A 258VAL A 214LEU A 211LEU A 142LEU A 249 | None | 1.09A | 4p65B-1woiA:undetectable4p65D-1woiA:undetectable4p65G-1woiA:undetectable4p65H-1woiA:undetectable | 4p65B-1woiA:8.374p65D-1woiA:8.374p65G-1woiA:4.504p65H-1woiA:8.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1z7c | CHORIONICSOMATOMAMMOTROPINHORMONE (Homo sapiens) |
PF00103(Hormone_1) | 5 | LEU A 93LEU A 87LEU A 23HIS A 112LEU A 113 | None | 1.05A | 4p65B-1z7cA:undetectable4p65D-1z7cA:undetectable4p65G-1z7cA:undetectable4p65H-1z7cA:undetectable | 4p65B-1z7cA:14.744p65D-1z7cA:14.744p65G-1z7cA:8.204p65H-1z7cA:14.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2aiz | OUTER MEMBRANEPROTEIN P6 (Haemophilusinfluenzae) |
PF00691(OmpA) | 5 | VAL P 66LEU P 132HIS P 52LEU P 49ALA P 53 | None | 1.04A | 4p65B-2aizP:undetectable4p65D-2aizP:undetectable4p65G-2aizP:undetectable4p65H-2aizP:undetectable | 4p65B-2aizP:12.694p65D-2aizP:12.694p65G-2aizP:16.674p65H-2aizP:12.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ass | S-PHASEKINASE-ASSOCIATEDPROTEIN 2 (Homo sapiens) |
PF12937(F-box-like) | 5 | LEU B2235VAL B2183LEU B2213CYH B2205LEU B2202 | None | 1.11A | 4p65B-2assB:undetectable4p65D-2assB:undetectable4p65G-2assB:undetectable4p65H-2assB:undetectable | 4p65B-2assB:7.374p65D-2assB:7.374p65G-2assB:7.114p65H-2assB:7.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b8e | CATION-TRANSPORTINGATPASE (Archaeoglobusfulgidus) |
PF00702(Hydrolase) | 5 | LEU A 586LEU A 561LEU A 429LEU A 655ALA A 554 | None | 1.16A | 4p65B-2b8eA:undetectable4p65D-2b8eA:undetectable4p65G-2b8eA:undetectable4p65H-2b8eA:undetectable | 4p65B-2b8eA:8.134p65D-2b8eA:8.134p65G-2b8eA:8.704p65H-2b8eA:8.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b8e | CATION-TRANSPORTINGATPASE (Archaeoglobusfulgidus) |
PF00702(Hydrolase) | 5 | LEU A 586VAL A 421LEU A 561LEU A 429ALA A 554 | None | 1.00A | 4p65B-2b8eA:undetectable4p65D-2b8eA:undetectable4p65G-2b8eA:undetectable4p65H-2b8eA:undetectable | 4p65B-2b8eA:8.134p65D-2b8eA:8.134p65G-2b8eA:8.704p65H-2b8eA:8.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dul | N(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASE (Pyrococcushorikoshii) |
PF02005(TRM) | 5 | VAL A 162LEU A 137LEU A 233LEU A 151ALA A 154 | None | 0.82A | 4p65B-2dulA:undetectable4p65D-2dulA:undetectable4p65G-2dulA:undetectable4p65H-2dulA:undetectable | 4p65B-2dulA:6.124p65D-2dulA:6.124p65G-2dulA:4.184p65H-2dulA:6.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ffh | PROTEIN (FFH) (Thermusaquaticus) |
PF00448(SRP54)PF02881(SRP54_N)PF02978(SRP_SPB) | 5 | LEU A 86VAL A 78LEU A 292LEU A 257LEU A 5 | None | 1.06A | 4p65B-2ffhA:undetectable4p65D-2ffhA:undetectable4p65G-2ffhA:undetectable4p65H-2ffhA:undetectable | 4p65B-2ffhA:6.364p65D-2ffhA:6.364p65G-2ffhA:4.724p65H-2ffhA:6.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g8l | 287AA LONGHYPOTHETICAL PROTEIN (Pyrococcushorikoshii) |
PF01937(DUF89) | 5 | LEU A 133LEU A 167CYH A 280LEU A 259ALA A 104 | None | 1.15A | 4p65B-2g8lA:undetectable4p65D-2g8lA:undetectable4p65G-2g8lA:undetectable4p65H-2g8lA:undetectable | 4p65B-2g8lA:7.174p65D-2g8lA:7.174p65G-2g8lA:4.424p65H-2g8lA:7.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gnw | NON-SYMBIOTICHEMOGLOBIN 1 (Oryza sativa) |
PF00042(Globin) | 5 | LEU A 88LEU A 101HIS A 152LEU A 153ALA A 156 | NoneNoneNoneHEM A 166 ( 4.7A)None | 1.13A | 4p65B-2gnwA:undetectable4p65D-2gnwA:undetectable4p65G-2gnwA:undetectable4p65H-2gnwA:undetectable | 4p65B-2gnwA:9.704p65D-2gnwA:9.704p65G-2gnwA:5.454p65H-2gnwA:9.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ng1 | SIGNAL SEQUENCERECOGNITION PROTEINFFH (Thermusaquaticus) |
PF00448(SRP54)PF02881(SRP54_N) | 5 | LEU A 86VAL A 78LEU A 292LEU A 257LEU A 5 | None | 1.09A | 4p65B-2ng1A:undetectable4p65D-2ng1A:undetectable4p65G-2ng1A:undetectable4p65H-2ng1A:undetectable | 4p65B-2ng1A:7.644p65D-2ng1A:7.644p65G-2ng1A:5.154p65H-2ng1A:7.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q0f | RNA URIDYLYLTRANSFERASE (Trypanosomabrucei) |
PF03828(PAP_assoc) | 5 | LEU A 329LEU A 177HIS A 320LEU A 321ALA A 324 | None | 1.01A | 4p65B-2q0fA:undetectable4p65D-2q0fA:undetectable4p65G-2q0fA:undetectable4p65H-2q0fA:undetectable | 4p65B-2q0fA:6.344p65D-2q0fA:6.344p65G-2q0fA:5.484p65H-2q0fA:6.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q0f | RNA URIDYLYLTRANSFERASE (Trypanosomabrucei) |
PF03828(PAP_assoc) | 5 | LEU A 329LEU A 177LEU A 245HIS A 320ALA A 324 | None | 1.08A | 4p65B-2q0fA:undetectable4p65D-2q0fA:undetectable4p65G-2q0fA:undetectable4p65H-2q0fA:undetectable | 4p65B-2q0fA:6.344p65D-2q0fA:6.344p65G-2q0fA:5.484p65H-2q0fA:6.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qg1 | MULTIPLE PDZ DOMAINPROTEIN (Homo sapiens) |
PF00595(PDZ) | 5 | LEU A1766VAL A1775LEU A1738LEU A1736ALA A1760 | None | 1.14A | 4p65B-2qg1A:undetectable4p65D-2qg1A:undetectable4p65G-2qg1A:undetectable4p65H-2qg1A:undetectable | 4p65B-2qg1A:21.314p65D-2qg1A:21.314p65G-2qg1A:10.234p65H-2qg1A:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ucz | UBIQUITINCONJUGATING ENZYME (Saccharomycescerevisiae) |
PF00179(UQ_con) | 5 | LEU A 16LEU A 9LEU A 120LEU A 58ALA A 26 | None | 1.03A | 4p65B-2uczA:undetectable4p65D-2uczA:undetectable4p65G-2uczA:undetectable4p65H-2uczA:undetectable | 4p65B-2uczA:11.454p65D-2uczA:11.454p65G-2uczA:11.304p65H-2uczA:11.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vg2 | UNDECAPRENYLPYROPHOSPHATESYNTHETASE (Mycobacteriumtuberculosis) |
PF01255(Prenyltransf) | 5 | LEU A 115CYH A 283LEU A 279LEU A 110ALA A 107 | None | 1.14A | 4p65B-2vg2A:undetectable4p65D-2vg2A:undetectable4p65G-2vg2A:undetectable4p65H-2vg2A:undetectable | 4p65B-2vg2A:9.334p65D-2vg2A:9.334p65G-2vg2A:10.004p65H-2vg2A:9.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2voy | CATION-TRANSPORTINGATPASE (Archaeoglobusfulgidus) |
PF00702(Hydrolase) | 5 | LEU I 586LEU I 561LEU I 429LEU I 655ALA I 554 | None | 1.16A | 4p65B-2voyI:undetectable4p65D-2voyI:undetectable4p65G-2voyI:undetectable4p65H-2voyI:undetectable | 4p65B-2voyI:15.154p65D-2voyI:15.154p65G-2voyI:9.894p65H-2voyI:15.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2voy | CATION-TRANSPORTINGATPASE (Archaeoglobusfulgidus) |
PF00702(Hydrolase) | 5 | LEU I 586VAL I 421LEU I 561LEU I 429ALA I 554 | None | 1.00A | 4p65B-2voyI:undetectable4p65D-2voyI:undetectable4p65G-2voyI:undetectable4p65H-2voyI:undetectable | 4p65B-2voyI:15.154p65D-2voyI:15.154p65G-2voyI:9.894p65H-2voyI:15.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wmm | CHROMOSOME PARTITIONPROTEIN MUKB (Escherichiacoli) |
PF16330(MukB_hinge) | 5 | LEU A 677VAL A 714LEU A 734HIS A 723LEU A 724 | None | 1.16A | 4p65B-2wmmA:undetectable4p65D-2wmmA:undetectable4p65G-2wmmA:undetectable4p65H-2wmmA:undetectable | 4p65B-2wmmA:11.184p65D-2wmmA:11.184p65G-2wmmA:9.024p65H-2wmmA:11.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x32 | CELLULOSE-BINDINGPROTEIN (Saccharophagusdegradans) |
PF04264(YceI) | 5 | LEU A 47VAL A 164LEU A 12LEU A 104ALA A 74 | NoneOTP A1174 ( 4.6A)NoneOTP A1174 ( 4.5A)OTP A1174 ( 4.9A) | 1.15A | 4p65B-2x32A:undetectable4p65D-2x32A:undetectable4p65G-2x32A:undetectable4p65H-2x32A:undetectable | 4p65B-2x32A:11.594p65D-2x32A:11.594p65G-2x32A:11.674p65H-2x32A:11.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x8u | SERINEPALMITOYLTRANSFERASE (Sphingomonaswittichii) |
PF00155(Aminotran_1_2) | 5 | VAL A 332LEU A 320LEU A 373HIS A 310LEU A 309 | None | 1.01A | 4p65B-2x8uA:undetectable4p65D-2x8uA:undetectable4p65G-2x8uA:undetectable4p65H-2x8uA:undetectable | 4p65B-2x8uA:6.764p65D-2x8uA:6.764p65G-2x8uA:12.044p65H-2x8uA:6.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yzm | D-ALANINE--D-ALANINELIGASE (Thermusthermophilus) |
PF01820(Dala_Dala_lig_N)PF07478(Dala_Dala_lig_C) | 5 | LEU A 4VAL A 91LEU A 81LEU A 69ALA A 35 | None | 1.12A | 4p65B-2yzmA:undetectable4p65D-2yzmA:undetectable4p65G-2yzmA:undetectable4p65H-2yzmA:undetectable | 4p65B-2yzmA:7.214p65D-2yzmA:7.214p65G-2yzmA:4.384p65H-2yzmA:7.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z0q | RHO GUANINENUCLEOTIDE EXCHANGEFACTOR 3 (Mus musculus) |
PF00621(RhoGEF) | 5 | LEU A 95LEU A 160HIS A 176LEU A 177ALA A 180 | None | 1.00A | 4p65B-2z0qA:undetectable4p65D-2z0qA:undetectable4p65G-2z0qA:undetectable4p65H-2z0qA:undetectable | 4p65B-2z0qA:7.254p65D-2z0qA:7.254p65G-2z0qA:4.854p65H-2z0qA:7.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3a9g | PUTATIVEUNCHARACTERIZEDPROTEIN (Pyrobaculumaerophilum) |
PF07995(GSDH) | 5 | LEU A 95LEU A 70LEU A 97LEU A 54ALA A 52 | None | 1.07A | 4p65B-3a9gA:undetectable4p65D-3a9gA:undetectable4p65G-3a9gA:undetectable4p65H-3a9gA:undetectable | 4p65B-3a9gA:5.954p65D-3a9gA:5.954p65G-3a9gA:4.124p65H-3a9gA:5.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3auz | DNA DOUBLE-STRANDBREAK REPAIR PROTEINMRE11 (Methanocaldococcusjannaschii) |
PF00149(Metallophos) | 5 | LEU A 100VAL A 44LEU A 71LEU A 50ALA A 64 | None | 1.06A | 4p65B-3auzA:undetectable4p65D-3auzA:undetectable4p65G-3auzA:undetectable4p65H-3auzA:undetectable | 4p65B-3auzA:7.074p65D-3auzA:7.074p65G-3auzA:4.824p65H-3auzA:7.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3b0h | NITRITE REDUCTASE (Nicotianatabacum) |
PF01077(NIR_SIR)PF03460(NIR_SIR_ferr) | 5 | VAL A 227LEU A 244LEU A 221CYH A 289LEU A 293 | None | 1.01A | 4p65B-3b0hA:undetectable4p65D-3b0hA:undetectable4p65G-3b0hA:undetectable4p65H-3b0hA:undetectable | 4p65B-3b0hA:4.944p65D-3b0hA:4.944p65G-3b0hA:3.984p65H-3b0hA:4.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cit | SENSOR HISTIDINEKINASE (Pseudomonassyringae groupgenomosp. 3) |
no annotation | 5 | LEU A 148LEU A 155LEU A 131LEU A 51ALA A 54 | None | 0.88A | 4p65B-3citA:undetectable4p65D-3citA:undetectable4p65G-3citA:undetectable4p65H-3citA:undetectable | 4p65B-3citA:14.414p65D-3citA:14.414p65G-3citA:11.904p65H-3citA:14.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3e7w | D-ALANINE--POLY(PHOSPHORIBITOL) LIGASESUBUNIT 1 (Bacillussubtilis) |
PF00501(AMP-binding)PF13193(AMP-binding_C) | 5 | LEU A 32LEU A 206CYH A 214LEU A 212ALA A 19 | None | 1.08A | 4p65B-3e7wA:undetectable4p65D-3e7wA:undetectable4p65G-3e7wA:undetectable4p65H-3e7wA:undetectable | 4p65B-3e7wA:7.974p65D-3e7wA:7.974p65G-3e7wA:3.914p65H-3e7wA:7.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3eap | RHOGTPASE-ACTIVATINGPROTEIN 11A (Homo sapiens) |
PF00620(RhoGAP) | 5 | LEU A 159LEU A 204HIS A 138LEU A 142ALA A 140 | None | 1.15A | 4p65B-3eapA:undetectable4p65D-3eapA:undetectable4p65G-3eapA:undetectable4p65H-3eapA:undetectable | 4p65B-3eapA:7.844p65D-3eapA:7.844p65G-3eapA:8.574p65H-3eapA:7.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fnr | ARGINYL-TRNASYNTHETASE (Campylobacterjejuni) |
PF00750(tRNA-synt_1d)PF05746(DALR_1) | 5 | LEU A 470LEU A 477LEU A 136LEU A 461ALA A 464 | None | 1.16A | 4p65B-3fnrA:undetectable4p65D-3fnrA:undetectable4p65G-3fnrA:undetectable4p65H-3fnrA:undetectable | 4p65B-3fnrA:4.834p65D-3fnrA:4.834p65G-3fnrA:5.644p65H-3fnrA:4.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g8m | SERINEHYDROXYMETHYLTRANSFERASE (Escherichiacoli) |
PF00464(SHMT) | 5 | LEU A 323VAL A 364LEU A 390LEU A 337ALA A 333 | None | 1.06A | 4p65B-3g8mA:undetectable4p65D-3g8mA:undetectable4p65G-3g8mA:undetectable4p65H-3g8mA:undetectable | 4p65B-3g8mA:6.494p65D-3g8mA:6.494p65G-3g8mA:4.904p65H-3g8mA:6.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h7n | NUCLEOPORIN NUP120 (Saccharomycescerevisiae) |
PF11715(Nup160) | 5 | LEU A 680VAL A 709LEU A 616LEU A 675ALA A 676 | None | 1.07A | 4p65B-3h7nA:undetectable4p65D-3h7nA:undetectable4p65G-3h7nA:undetectable4p65H-3h7nA:undetectable | 4p65B-3h7nA:4.714p65D-3h7nA:4.714p65G-3h7nA:2.594p65H-3h7nA:4.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hhr | HUMAN GROWTH HORMONE (Homo sapiens) |
PF00103(Hormone_1) | 5 | LEU A 177LEU A 117HIS A 21LEU A 20ALA A 17 | None | 1.06A | 4p65B-3hhrA:undetectable4p65D-3hhrA:undetectable4p65G-3hhrA:undetectable4p65H-3hhrA:undetectable | 4p65B-3hhrA:10.294p65D-3hhrA:10.294p65G-3hhrA:7.894p65H-3hhrA:10.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mdy | BONE MORPHOGENETICPROTEIN RECEPTORTYPE-1B (Homo sapiens) |
PF07714(Pkinase_Tyr)PF08515(TGF_beta_GS) | 5 | LEU A 407LEU A 463LEU A 491LEU A 302ALA A 305 | None | 1.14A | 4p65B-3mdyA:undetectable4p65D-3mdyA:undetectable4p65G-3mdyA:undetectable4p65H-3mdyA:undetectable | 4p65B-3mdyA:5.974p65D-3mdyA:5.974p65G-3mdyA:5.654p65H-3mdyA:5.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3no3 | GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE (Parabacteroidesdistasonis) |
PF03009(GDPD) | 5 | LEU A 47VAL A 62LEU A 120LEU A 109ALA A 112 | None | 1.14A | 4p65B-3no3A:undetectable4p65D-3no3A:undetectable4p65G-3no3A:undetectable4p65H-3no3A:undetectable | 4p65B-3no3A:7.984p65D-3no3A:7.984p65G-3no3A:8.184p65H-3no3A:7.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pdi | NITROGENASE MOFECOFACTORBIOSYNTHESIS PROTEINNIFN (Azotobactervinelandii) |
PF00148(Oxidored_nitro) | 5 | LEU B 431VAL B 423LEU B 424LEU B 332ALA B 314 | None | 1.01A | 4p65B-3pdiB:undetectable4p65D-3pdiB:undetectable4p65G-3pdiB:undetectable4p65H-3pdiB:undetectable | 4p65B-3pdiB:6.504p65D-3pdiB:6.504p65G-3pdiB:7.614p65H-3pdiB:6.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qr5 | CARDIAC CA2+ RELEASECHANNEL (Mus musculus) |
PF08709(Ins145_P3_rec) | 5 | LEU A 49CYH A 47LEU A 37HIS A 193LEU A 192 | None | 1.14A | 4p65B-3qr5A:undetectable4p65D-3qr5A:undetectable4p65G-3qr5A:undetectable4p65H-3qr5A:undetectable | 4p65B-3qr5A:13.614p65D-3qr5A:13.614p65G-3qr5A:8.814p65H-3qr5A:13.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sdi | PROTEASOME COMPONENTPRE5 (Saccharomycescerevisiae) |
PF00227(Proteasome)PF10584(Proteasome_A_N) | 5 | LEU E 107HIS E 73CYH E 70LEU E 92ALA E 112 | None | 1.03A | 4p65B-3sdiE:undetectable4p65D-3sdiE:undetectable4p65G-3sdiE:undetectable4p65H-3sdiE:undetectable | 4p65B-3sdiE:9.914p65D-3sdiE:9.914p65G-3sdiE:13.954p65H-3sdiE:9.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3so4 | METHIONINE-ADENOSYLTRANSFERASE (Entamoebahistolytica) |
PF00438(S-AdoMet_synt_N)PF02772(S-AdoMet_synt_M)PF02773(S-AdoMet_synt_C) | 5 | LEU A 382LEU A 388CYH A 298LEU A 292LEU A 332 | None | 1.13A | 4p65B-3so4A:undetectable4p65D-3so4A:undetectable4p65G-3so4A:undetectable4p65H-3so4A:undetectable | 4p65B-3so4A:3.954p65D-3so4A:3.954p65G-3so4A:5.504p65H-3so4A:3.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tz6 | ASPARTATE-SEMIALDEHYDE DEHYDROGENASE (Mycobacteriumtuberculosis) |
PF01118(Semialdhyde_dh)PF02774(Semialdhyde_dhC) | 5 | LEU A 317VAL A 321LEU A 142LEU A 277ALA A 273 | None | 1.00A | 4p65B-3tz6A:undetectable4p65D-3tz6A:undetectable4p65G-3tz6A:undetectable4p65H-3tz6A:undetectable | 4p65B-3tz6A:7.474p65D-3tz6A:7.474p65G-3tz6A:6.544p65H-3tz6A:7.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uet | ALPHA-1,3/4-FUCOSIDASE (Bifidobacteriumlongum) |
PF01120(Alpha_L_fucos) | 5 | LEU A 395VAL A 461LEU A 421LEU A 373ALA A 473 | None | 1.10A | 4p65B-3uetA:undetectable4p65D-3uetA:undetectable4p65G-3uetA:undetectable4p65H-3uetA:undetectable | 4p65B-3uetA:4.064p65D-3uetA:4.064p65G-3uetA:4.324p65H-3uetA:4.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4alz | YOP PROTEINSTRANSLOCATIONPROTEIN D (Yersiniaenterocolitica) |
PF16693(Yop-YscD_ppl) | 5 | LEU A 246VAL A 279LEU A 265LEU A 227ALA A 223 | None | 1.11A | 4p65B-4alzA:undetectable4p65D-4alzA:undetectable4p65G-4alzA:undetectable4p65H-4alzA:undetectable | 4p65B-4alzA:10.364p65D-4alzA:10.364p65G-4alzA:6.154p65H-4alzA:10.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4amm | DYNE8 (Micromonosporachersina) |
PF00698(Acyl_transf_1) | 5 | LEU A 566VAL A 481CYH A 483LEU A 543ALA A 546 | None | 1.11A | 4p65B-4ammA:undetectable4p65D-4ammA:undetectable4p65G-4ammA:undetectable4p65H-4ammA:undetectable | 4p65B-4ammA:7.054p65D-4ammA:7.054p65G-4ammA:5.704p65H-4ammA:7.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4amm | DYNE8 (Micromonosporachersina) |
PF00698(Acyl_transf_1) | 5 | VAL A 823LEU A 843LEU A 819LEU A 860ALA A 859 | None | 1.09A | 4p65B-4ammA:undetectable4p65D-4ammA:undetectable4p65G-4ammA:undetectable4p65H-4ammA:undetectable | 4p65B-4ammA:7.054p65D-4ammA:7.054p65G-4ammA:5.704p65H-4ammA:7.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bv4 | PROTEIN TOLL,VARIABLE LYMPHOCYTERECEPTOR B CHIMERA (Drosophilamelanogaster;Eptatretusburgeri) |
PF11921(DUF3439)PF13855(LRR_8) | 5 | VAL R 405LEU R 402LEU R 440LEU R 421ALA R 451 | None | 1.14A | 4p65B-4bv4R:undetectable4p65D-4bv4R:undetectable4p65G-4bv4R:undetectable4p65H-4bv4R:undetectable | 4p65B-4bv4R:6.024p65D-4bv4R:6.024p65G-4bv4R:5.314p65H-4bv4R:6.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dvg | RHO-LIKE SMALLGTPASE (Entamoebahistolytica) |
PF00071(Ras) | 6 | LEU A 172VAL A 25LEU A 96CYH A 98LEU A 132ALA A 164 | None | 1.50A | 4p65B-4dvgA:undetectable4p65D-4dvgA:undetectable4p65G-4dvgA:undetectable4p65H-4dvgA:undetectable | 4p65B-4dvgA:10.714p65D-4dvgA:10.714p65G-4dvgA:8.864p65H-4dvgA:10.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h05 | AMINOGLYCOSIDE-O-PHOSPHOTRANSFERASE VIII (Streptomycesrimosus) |
PF01636(APH) | 5 | LEU A 113VAL A 180LEU A 120LEU A 202LEU A 62 | None | 1.10A | 4p65B-4h05A:undetectable4p65D-4h05A:undetectable4p65G-4h05A:undetectable4p65H-4h05A:undetectable | 4p65B-4h05A:8.444p65D-4h05A:8.444p65G-4h05A:4.954p65H-4h05A:8.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4imv | RICIN (Ricinuscommunis) |
PF00161(RIP) | 5 | VAL A 81LEU A 74CYH A 171LEU A 144LEU A 62 | None | 1.16A | 4p65B-4imvA:undetectable4p65D-4imvA:undetectable4p65G-4imvA:undetectable4p65H-4imvA:undetectable | 4p65B-4imvA:15.174p65D-4imvA:15.174p65G-4imvA:6.454p65H-4imvA:15.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4knh | NUP192P (Chaetomiumthermophilum) |
PF11894(Nup192) | 5 | LEU A 840VAL A 894LEU A 797LEU A 886ALA A 883 | None | 1.16A | 4p65B-4knhA:undetectable4p65D-4knhA:undetectable4p65G-4knhA:undetectable4p65H-4knhA:undetectable | 4p65B-4knhA:2.954p65D-4knhA:2.954p65G-4knhA:2.024p65H-4knhA:2.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ldu | AUXIN RESPONSEFACTOR 5 (Arabidopsisthaliana) |
PF02362(B3)PF06507(Auxin_resp) | 5 | LEU A 106LEU A 102HIS A 80LEU A 281ALA A 284 | None | 1.10A | 4p65B-4lduA:undetectable4p65D-4lduA:undetectable4p65G-4lduA:undetectable4p65H-4lduA:undetectable | 4p65B-4lduA:6.574p65D-4lduA:6.574p65G-4lduA:5.374p65H-4lduA:6.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n6f | PUTATIVE THIOSUGARSYNTHASE (Amycolatopsisorientalis) |
PF05690(ThiG) | 5 | LEU A 109VAL A 113LEU A 132LEU A 94ALA A 97 | None | 1.12A | 4p65B-4n6fA:undetectable4p65D-4n6fA:undetectable4p65G-4n6fA:undetectable4p65H-4n6fA:undetectable | 4p65B-4n6fA:7.034p65D-4n6fA:7.034p65G-4n6fA:4.584p65H-4n6fA:7.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nph | PROBABLE SECRETIONSYSTEM APPARATUS ATPSYNTHASE SSAN (Salmonellaenterica) |
PF00006(ATP-synt_ab) | 5 | LEU A 249LEU A 325LEU A 230LEU A 254ALA A 251 | None | 0.81A | 4p65B-4nphA:undetectable4p65D-4nphA:undetectable4p65G-4nphA:undetectable4p65H-4nphA:undetectable | 4p65B-4nphA:8.984p65D-4nphA:8.984p65G-4nphA:5.994p65H-4nphA:8.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4pay | SIDC, INTERAPTIN (Legionellapneumophila) |
no annotation | 5 | LEU A 536VAL A 523LEU A 527LEU A 588LEU A 592 | None | 1.11A | 4p65B-4payA:undetectable4p65D-4payA:undetectable4p65G-4payA:undetectable4p65H-4payA:undetectable | 4p65B-4payA:4.704p65D-4payA:4.704p65G-4payA:3.594p65H-4payA:4.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ppz | SUCCINYL-DIAMINOPIMELATE DESUCCINYLASE (Neisseriameningitidis) |
PF01546(Peptidase_M20)PF07687(M20_dimer) | 5 | LEU A 277LEU A 252LEU A 216LEU A 213ALA A 212 | None | 1.07A | 4p65B-4ppzA:undetectable4p65D-4ppzA:undetectable4p65G-4ppzA:undetectable4p65H-4ppzA:undetectable | 4p65B-4ppzA:7.894p65D-4ppzA:7.894p65G-4ppzA:4.924p65H-4ppzA:7.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qnx | TRNA(MO5U34)-METHYLTRANSFERASE (Escherichiacoli) |
PF08003(Methyltransf_9) | 5 | LEU A 86VAL A 99LEU A 49LEU A 167ALA A 163 | None | 1.16A | 4p65B-4qnxA:undetectable4p65D-4qnxA:undetectable4p65G-4qnxA:undetectable4p65H-4qnxA:undetectable | 4p65B-4qnxA:7.744p65D-4qnxA:7.744p65G-4qnxA:6.854p65H-4qnxA:7.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rld | ASPARTIC PROTEASEBLA G 2 (Blattellagermanica) |
PF00026(Asp) | 5 | LEU A 53VAL A 30LEU A 115LEU A 107ALA A 49 | None | 1.00A | 4p65B-4rldA:undetectable4p65D-4rldA:undetectable4p65G-4rldA:undetectable4p65H-4rldA:undetectable | 4p65B-4rldA:9.954p65D-4rldA:9.954p65G-4rldA:5.364p65H-4rldA:9.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rqo | L-SERINE DEHYDRATASE (Legionellapneumophila) |
PF03313(SDH_alpha)PF03315(SDH_beta) | 5 | LEU A 425LEU A 329CYH A 183LEU A 179ALA A 176 | None | 1.16A | 4p65B-4rqoA:undetectable4p65D-4rqoA:undetectable4p65G-4rqoA:undetectable4p65H-4rqoA:undetectable | 4p65B-4rqoA:5.064p65D-4rqoA:5.064p65G-4rqoA:5.004p65H-4rqoA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wja | UNCHARACTERIZEDPROTEIN C9ORF142 (Homo sapiens) |
PF15384(PAXX) | 5 | LEU A 89LEU A 47CYH A 22LEU A 87ALA A 94 | None | 1.16A | 4p65B-4wjaA:undetectable4p65D-4wjaA:undetectable4p65G-4wjaA:undetectable4p65H-4wjaA:undetectable | 4p65B-4wjaA:11.184p65D-4wjaA:11.184p65G-4wjaA:11.464p65H-4wjaA:11.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x3m | RNA 2'-O RIBOSEMETHYLTRANSFERASE (Thermusthermophilus) |
PF00588(SpoU_methylase) | 5 | VAL A 140LEU A 114LEU A 162LEU A 127ALA A 130 | None | 0.96A | 4p65B-4x3mA:undetectable4p65D-4x3mA:undetectable4p65G-4x3mA:undetectable4p65H-4x3mA:undetectable | 4p65B-4x3mA:9.814p65D-4x3mA:9.814p65G-4x3mA:5.564p65H-4x3mA:9.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yii | UBIQUITIN-CONJUGATING ENZYME E2 C (Homo sapiens) |
PF00179(UQ_con) | 5 | LEU U 42LEU U 35LEU U 132LEU U 83ALA U 52 | None | 1.09A | 4p65B-4yiiU:undetectable4p65D-4yiiU:undetectable4p65G-4yiiU:undetectable4p65H-4yiiU:undetectable | 4p65B-4yiiU:11.034p65D-4yiiU:11.034p65G-4yiiU:8.064p65H-4yiiU:11.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yu5 | IMMUNE INHIBITOR A,METALLOPROTEASE (Bacillus cereus) |
PF05547(Peptidase_M6) | 5 | LEU A 241LEU A 169HIS A 275LEU A 274ALA A 277 | None | 1.09A | 4p65B-4yu5A:undetectable4p65D-4yu5A:undetectable4p65G-4yu5A:undetectable4p65H-4yu5A:undetectable | 4p65B-4yu5A:3.944p65D-4yu5A:3.944p65G-4yu5A:2.584p65H-4yu5A:3.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5a22 | VESICULAR STOMATITISVIRUS L POLYMERASE (Vesicularstomatitisvirus) |
PF00946(Mononeg_RNA_pol)PF14314(Methyltrans_Mon)PF14318(Mononeg_mRNAcap) | 5 | LEU A1069LEU A1063LEU A 880CYH A 808ALA A 876 | None | 1.13A | 4p65B-5a22A:undetectable4p65D-5a22A:undetectable4p65G-5a22A:undetectable4p65H-5a22A:undetectable | 4p65B-5a22A:1.684p65D-5a22A:1.684p65G-5a22A:1.074p65H-5a22A:1.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5a46 | FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | LEU A 689CYH A 603LEU A 569LEU A 573ALA A 626 | None | 1.14A | 4p65B-5a46A:undetectable4p65D-5a46A:undetectable4p65G-5a46A:undetectable4p65H-5a46A:undetectable | 4p65B-5a46A:6.774p65D-5a46A:6.774p65G-5a46A:3.954p65H-5a46A:6.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5aga | DNA POLYMERASE THETA (Homo sapiens) |
PF00270(DEAD)PF00271(Helicase_C) | 5 | LEU A 446LEU A 420LEU A 440HIS A 417ALA A 442 | None | 1.15A | 4p65B-5agaA:undetectable4p65D-5agaA:undetectable4p65G-5agaA:undetectable4p65H-5agaA:undetectable | 4p65B-5agaA:4.514p65D-5agaA:4.514p65G-5agaA:2.844p65H-5agaA:4.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5azd | BACTERIORHODOPSIN (Thermusthermophilus) |
PF01036(Bac_rhodopsin) | 5 | LEU A 170VAL A 183LEU A 184LEU A 113ALA A 173 | None | 1.01A | 4p65B-5azdA:undetectable4p65D-5azdA:undetectable4p65G-5azdA:undetectable4p65H-5azdA:undetectable | 4p65B-5azdA:13.044p65D-5azdA:13.044p65G-5azdA:16.184p65H-5azdA:13.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cio | PYRROLOQUINOLINEQUINONE BIOSYNTHESISPROTEIN PQQF (Serratia sp.FS14) |
PF00675(Peptidase_M16)PF05193(Peptidase_M16_C) | 5 | LEU A 391LEU A 408CYH A 141LEU A 388ALA A 389 | None | 1.14A | 4p65B-5cioA:undetectable4p65D-5cioA:undetectable4p65G-5cioA:undetectable4p65H-5cioA:undetectable | 4p65B-5cioA:3.524p65D-5cioA:3.524p65G-5cioA:11.014p65H-5cioA:3.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ckm | MANNAN-BINDINGLECTIN SERINEPEPTIDASE 2 (Rattusnorvegicus) |
PF00431(CUB)PF07645(EGF_CA) | 5 | LEU A 67VAL A 58LEU A 70LEU A 94LEU A 40 | None | 1.04A | 4p65B-5ckmA:undetectable4p65D-5ckmA:undetectable4p65G-5ckmA:undetectable4p65H-5ckmA:undetectable | 4p65B-5ckmA:6.274p65D-5ckmA:6.274p65G-5ckmA:6.284p65H-5ckmA:6.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5czz | CRISPR-ASSOCIATEDENDONUCLEASE CAS9 (Staphylococcusaureus) |
PF13395(HNH_4)PF16592(Cas9_REC) | 5 | LEU A 100HIS A 191LEU A 76LEU A 183LEU A 109 | None | 1.10A | 4p65B-5czzA:undetectable4p65D-5czzA:undetectable4p65G-5czzA:undetectable4p65H-5czzA:undetectable | 4p65B-5czzA:4.054p65D-5czzA:4.054p65G-5czzA:2.014p65H-5czzA:4.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5d9a | RNA-DIRECTED RNAPOLYMERASE CATALYTICSUBUNIT (Influenza Cvirus) |
PF00602(Flu_PB1) | 5 | VAL B 419LEU B 416LEU B 90LEU B 323ALA B 319 | None | 1.13A | 4p65B-5d9aB:undetectable4p65D-5d9aB:undetectable4p65G-5d9aB:undetectable4p65H-5d9aB:undetectable | 4p65B-5d9aB:4.174p65D-5d9aB:4.174p65G-5d9aB:4.024p65H-5d9aB:4.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dgx | LIPID A EXPORTATP-BINDING/PERMEASEPROTEIN MSBA (Francisellatularensis) |
PF00005(ABC_tran) | 5 | VAL A 372LEU A 430HIS A 446LEU A 447ALA A 527 | None | 1.14A | 4p65B-5dgxA:undetectable4p65D-5dgxA:undetectable4p65G-5dgxA:undetectable4p65H-5dgxA:undetectable | 4p65B-5dgxA:10.344p65D-5dgxA:10.344p65G-5dgxA:15.794p65H-5dgxA:10.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dny | DNA DOUBLE-STRANDBREAK REPAIR PROTEINMRE11 (Methanocaldococcusjannaschii) |
PF00149(Metallophos) | 5 | LEU A 100VAL A 44LEU A 71LEU A 50ALA A 64 | None | 1.08A | 4p65B-5dnyA:undetectable4p65D-5dnyA:undetectable4p65G-5dnyA:undetectable4p65H-5dnyA:undetectable | 4p65B-5dnyA:6.674p65D-5dnyA:6.674p65G-5dnyA:4.474p65H-5dnyA:6.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ejy | MYOSIN-I HEAVY CHAIN (Dictyosteliumdiscoideum) |
PF00784(MyTH4) | 5 | LEU A 514LEU A 497LEU A 466LEU A 524ALA A 516 | None | 1.08A | 4p65B-5ejyA:undetectable4p65D-5ejyA:undetectable4p65G-5ejyA:undetectable4p65H-5ejyA:undetectable | 4p65B-5ejyA:4.744p65D-5ejyA:4.744p65G-5ejyA:7.264p65H-5ejyA:4.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fo5 | HTH-TYPETRANSCRIPTIONALREGULATOR METR (Escherichiacoli) |
PF00126(HTH_1) | 5 | LEU A 33LEU A 40LEU A 13HIS A 6LEU A 10 | None | 0.93A | 4p65B-5fo5A:undetectable4p65D-5fo5A:undetectable4p65G-5fo5A:undetectable4p65H-5fo5A:undetectable | 4p65B-5fo5A:16.854p65D-5fo5A:16.854p65G-5fo5A:13.104p65H-5fo5A:16.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gvi | UBIQUITINCARBOXYL-TERMINALHYDROLASE 30 (Danio rerio) |
PF00443(UCH) | 5 | LEU A 66LEU A 161LEU A 119LEU A 139ALA A 136 | None | 1.04A | 4p65B-5gviA:undetectable4p65D-5gviA:undetectable4p65G-5gviA:undetectable4p65H-5gviA:undetectable | 4p65B-5gviA:5.744p65D-5gviA:5.744p65G-5gviA:5.174p65H-5gviA:5.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | LEU A 64LEU A 151HIS A 77LEU A 89ALA A 62 | None | 1.03A | 4p65B-5hjrA:undetectable4p65D-5hjrA:undetectable4p65G-5hjrA:undetectable4p65H-5hjrA:undetectable | 4p65B-5hjrA:3.314p65D-5hjrA:3.314p65G-5hjrA:2.594p65H-5hjrA:3.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ijb | TOLL-LIKE RECEPTOR4, VARIABLELYMPHOCYTE RECEPTORB CHIMERA (Eptatretusburgeri;Mus musculus) |
PF00560(LRR_1)PF11921(DUF3439)PF13855(LRR_8) | 5 | VAL A 557LEU A 554LEU A 592LEU A 573ALA A 603 | None | 1.13A | 4p65B-5ijbA:undetectable4p65D-5ijbA:undetectable4p65G-5ijbA:undetectable4p65H-5ijbA:undetectable | 4p65B-5ijbA:4.124p65D-5ijbA:4.124p65G-5ijbA:3.844p65H-5ijbA:4.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5k7f | TRANSCRIPTIONALREGULATOR, TETRFAMILY (Myxococcusxanthus) |
PF00440(TetR_N) | 5 | VAL A 76LEU A 77LEU A 90LEU A 138ALA A 141 | None | 0.84A | 4p65B-5k7fA:undetectable4p65D-5k7fA:undetectable4p65G-5k7fA:undetectable4p65H-5k7fA:undetectable | 4p65B-5k7fA:9.384p65D-5k7fA:9.384p65G-5k7fA:14.004p65H-5k7fA:9.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5n6v | AMYLOSUCRASE (Neisseriapolysaccharea) |
no annotation | 5 | LEU A 172CYH A 103HIS A 131LEU A 130ALA A 179 | None | 1.14A | 4p65B-5n6vA:undetectable4p65D-5n6vA:undetectable4p65G-5n6vA:undetectable4p65H-5n6vA:undetectable | 4p65B-5n6vA:undetectable4p65D-5n6vA:undetectable4p65G-5n6vA:undetectable4p65H-5n6vA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohk | UBIQUITINCARBOXYL-TERMINALHYDROLASE30,UBIQUITINCARBOXYL-TERMINALHYDROLASE30,UBIQUITINCARBOXYL-TERMINALHYDROLASE 30 (Homo sapiens) |
PF00443(UCH) | 5 | LEU A 70LEU A 165LEU A 123LEU A 143ALA A 140 | None | 0.99A | 4p65B-5ohkA:undetectable4p65D-5ohkA:undetectable4p65G-5ohkA:undetectable4p65H-5ohkA:undetectable | 4p65B-5ohkA:7.674p65D-5ohkA:7.674p65G-5ohkA:4.174p65H-5ohkA:7.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5t3b | GLYCOSIDE HYDROLASE (Bacteroidesplebeius) |
no annotation | 5 | LEU A 192VAL A 197LEU A 174CYH A 288LEU A 242 | None | 1.06A | 4p65B-5t3bA:undetectable4p65D-5t3bA:undetectable4p65G-5t3bA:undetectable4p65H-5t3bA:undetectable | 4p65B-5t3bA:4.794p65D-5t3bA:4.794p65G-5t3bA:4.264p65H-5t3bA:4.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u4z | REPRESSOR OF RNAPOLYMERASE IIITRANSCRIPTION (Citrus sinensis) |
PF09174(Maf1) | 5 | LEU A 9LEU A 16LEU A 145LEU A 141ALA A 144 | None | 1.14A | 4p65B-5u4zA:undetectable4p65D-5u4zA:undetectable4p65G-5u4zA:undetectable4p65H-5u4zA:undetectable | 4p65B-5u4zA:7.944p65D-5u4zA:7.944p65G-5u4zA:5.704p65H-5u4zA:7.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5un0 | PROTEASOME ASSEMBLYCHAPERONE 2 (PAC2)HOMOLOGUE RV2125 (Mycobacteriumtuberculosis) |
PF09754(PAC2) | 5 | LEU 1 129VAL 1 95LEU 1 97LEU 1 209ALA 1 35 | None | 1.09A | 4p65B-5un01:undetectable4p65D-5un01:undetectable4p65G-5un01:undetectable4p65H-5un01:undetectable | 4p65B-5un01:12.794p65D-5un01:12.794p65G-5un01:5.534p65H-5un01:12.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ux2 | ALDEHYDEDECARBONYLASE (Synechococcussp. RS9917) |
no annotation | 5 | CYH A 110LEU A 106HIS A 141LEU A 142ALA A 145 | NoneNone FE A 301 (-3.5A)NoneNone | 1.03A | 4p65B-5ux2A:undetectable4p65D-5ux2A:undetectable4p65G-5ux2A:undetectable4p65H-5ux2A:undetectable | 4p65B-5ux2A:undetectable4p65D-5ux2A:undetectable4p65G-5ux2A:undetectable4p65H-5ux2A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vip | MDCD (Pseudomonasaeruginosa) |
PF01039(Carboxyl_trans) | 5 | LEU B 16VAL B 152LEU B 115LEU B 229ALA B 24 | None | 1.16A | 4p65B-5vipB:undetectable4p65D-5vipB:undetectable4p65G-5vipB:undetectable4p65H-5vipB:undetectable | 4p65B-5vipB:8.004p65D-5vipB:8.004p65G-5vipB:5.494p65H-5vipB:8.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w19 | TRYPTOPHANASE (Proteusvulgaris) |
no annotation | 5 | LEU A 444VAL A 357LEU A 437LEU A 380ALA A 379 | None | 1.01A | 4p65B-5w19A:undetectable4p65D-5w19A:undetectable4p65G-5w19A:undetectable4p65H-5w19A:undetectable | 4p65B-5w19A:undetectable4p65D-5w19A:undetectable4p65G-5w19A:undetectable4p65H-5w19A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x4j | UNCHARACTERIZEDPROTEIN (Pyrococcusfuriosus) |
no annotation | 5 | LEU A 459VAL A 359LEU A 464LEU A 426ALA A 429 | None | 1.07A | 4p65B-5x4jA:undetectable4p65D-5x4jA:undetectable4p65G-5x4jA:undetectable4p65H-5x4jA:undetectable | 4p65B-5x4jA:undetectable4p65D-5x4jA:undetectable4p65G-5x4jA:undetectable4p65H-5x4jA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xeq | NEUROLIGIN-2 (Homo sapiens) |
PF00135(COesterase) | 5 | LEU A 144LEU A 183LEU A 245LEU A 242ALA A 241 | None | 1.09A | 4p65B-5xeqA:undetectable4p65D-5xeqA:undetectable4p65G-5xeqA:undetectable4p65H-5xeqA:undetectable | 4p65B-5xeqA:5.024p65D-5xeqA:5.024p65G-5xeqA:3.384p65H-5xeqA:5.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cn7 | AEROBACTIN SYNTHASEIUCC (Klebsiellapneumoniae) |
no annotation | 5 | LEU A 78VAL A 84LEU A 41LEU A 548LEU A 21 | None | 1.17A | 4p65B-6cn7A:undetectable4p65D-6cn7A:undetectable4p65G-6cn7A:undetectable4p65H-6cn7A:undetectable | 4p65B-6cn7A:undetectable4p65D-6cn7A:undetectable4p65G-6cn7A:undetectable4p65H-6cn7A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6grw | - (-) |
no annotation | 5 | LEU A 118LEU A 204LEU A 137LEU A 243ALA A 246 | None | 1.01A | 4p65B-6grwA:undetectable4p65D-6grwA:undetectable4p65G-6grwA:undetectable4p65H-6grwA:undetectable | 4p65B-6grwA:undetectable4p65D-6grwA:undetectable4p65G-6grwA:undetectable4p65H-6grwA:undetectable |